NLX-112, a full and potent 5-HT1A agonist, as a potential pharmacological treatment for Machado-Joseph Disease - Lessons from the worm uri icon

autores

  • Joana Catarina Pereira de Sousa
  • Lomba, B.
  • Varney, M. A.
  • Newman-Tancredi, A.
  • Teixeira-Castro, A. (8113-D13B-DD48)
  • Maciel, P.

data de publicação

  • janeiro 1, 2019